MNK-1411 is an injection composed of a formulation of tetracosactide, which is a synthetic melanocortin receptor agonist. Melanocortin receptor …
FDA Grants Orphan Designation to Mallinckrodt’s potential drug for DuchenneRead More
- Menu
- Skip to right header navigation
- Skip to main content
- Skip to secondary navigation
- Skip to footer
Footer
